Bortezomib in Combination with Physachenolide C Reduces the Tumorigenic Properties of KRAS mut /P53 mut Lung Cancer Cells by Inhibiting c-FLIP.
Thanigaivelan KanagasabaiZerick DunbarSalvador González OchoaTonie FarrisSivanesan DhandayuthapaniE M Kithsiri WijeratneA A Leslie GunatilakaAnil ShankerPublished in: Cancers (2024)
lung cancer cells, with an enhanced efficacy of combination treatments without causing significant side effects.